These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 1858413)
1. Prevention of infections of the respiratory tract using the oral application of antigens. Tischner H Z Erkr Atmungsorgane; 1991; 176(2-3):131-7. PubMed ID: 1858413 [No Abstract] [Full Text] [Related]
2. [Oral administration of "Infectvac" for prevention of acute respiratory tract infections]. Luther P; Brachmann I; Werchan D; Wittig C; Tischner H Z Erkr Atmungsorgane; 1990; 175(2):95-9. PubMed ID: 2264367 [TBL] [Abstract][Full Text] [Related]
3. [Immunization in pneumology]. Schaberg T; Lode H Pneumologie; 1994 Aug; 48(8):505-10. PubMed ID: 7971886 [No Abstract] [Full Text] [Related]
5. Intranasal vaccines for protection against respiratory and systemic bacterial infections. Oliveira ML; Arêas AP; Ho PL Expert Rev Vaccines; 2007 Jun; 6(3):419-29. PubMed ID: 17542756 [TBL] [Abstract][Full Text] [Related]
6. [Assessment of salivary IgA titer in children with recurrent respiratory infections treated with polyvalent oral vaccine. A controlled study]. Cimadamore N; Agriesti G; Testa A; Borgarello R; Capo G; Crua G Minerva Pediatr; 1988 Jun; 40(6):355-60. PubMed ID: 3054472 [No Abstract] [Full Text] [Related]
7. Vaccinology in the prophylaxis of respiratory infections--Part II. Griffin JP Clin Notes Respir Dis; 1978; 17(2):3-12. PubMed ID: 699411 [No Abstract] [Full Text] [Related]
8. Problems and progress towards vaccination against bacterial infections of the respiratory tract. Artenstein MS Dev Biol Stand; 1975; 28():115-25. PubMed ID: 236208 [TBL] [Abstract][Full Text] [Related]
11. Reduction of the number and severity of respiratory tract infections in children by oral immunostimulation. Riedl-Seifert RJ; van Aubel A; Kämmereit A; Elsasser U Adv Exp Med Biol; 1995; 371B():799-802. PubMed ID: 7502900 [No Abstract] [Full Text] [Related]
12. [Status and prospects of immunologic disease prevention]. Morunova AA Pediatriia; 1989; (7):5-7. PubMed ID: 2780160 [No Abstract] [Full Text] [Related]
13. [Communicable diseases in Norway. Epidemiological status and future challenge for prevention of the most important diseases]. Lystad A; Flugsrud LB Tidsskr Nor Laegeforen; 1995 Sep; 115(23):2899-903. PubMed ID: 7570514 [TBL] [Abstract][Full Text] [Related]
14. DNA vaccines for biodefence. Garmory HS; Perkins SD; Phillpotts RJ; Titball RW Adv Drug Deliv Rev; 2005 Jun; 57(9):1343-61. PubMed ID: 15935877 [TBL] [Abstract][Full Text] [Related]
15. Mucosal vaccines: novel advances in technology and delivery. Yuki Y; Kiyono H Expert Rev Vaccines; 2009 Aug; 8(8):1083-97. PubMed ID: 19627189 [TBL] [Abstract][Full Text] [Related]
16. Letter from the editor. Ellis R; Riedmann EM Hum Vaccin Immunother; 2014; 10(7):1771-2. PubMed ID: 25424780 [No Abstract] [Full Text] [Related]
17. Identifying vaccine antigens and assessing delivery systems for the prevention of bacterial infections. Kyd J; Cripps A J Biotechnol; 2000 Sep; 83(1-2):85-90. PubMed ID: 11000464 [TBL] [Abstract][Full Text] [Related]